Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.3031
+0.0121 (4.16%)
At close: Nov 4, 2026, 4:00 PM EST
0.3075
+0.0044 (1.45%)
After-hours: Nov 4, 2026, 7:15 PM EST
Mereo BioPharma Group Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 48 | 51 | 53 | 66 | 328 | 431 | 358 | 542 | 631 | 549 | 462 | 323 | 161 | 165 | 88 | 88 | 101 | 131 | 131 | 174 | 263 | |
Market Cap Growth (YoY) | -83.99% | -88.23% | -85.28% | -87.77% | -48.09% | -21.54% | -22.57% | 67.64% | 292.34% | 233.55% | 423.98% | 269.38% | 60.08% | 25.94% | -32.56% | -49.64% | -61.77% | -61.81% | -64.08% | -28.05% | 48.69% |
Enterprise Value | 19 | 14 | 12 | 18 | 272 | 369 | 294 | 468 | 550 | 507 | 411 | 282 | 119 | 112 | 36 | 17 | -4 | 26 | 26 | 50 | 255 |
Last Close Price | 0.29 | 0.32 | 0.33 | 0.42 | 2.06 | 2.71 | 2.25 | 3.50 | 4.11 | 3.60 | 3.30 | 2.31 | 1.29 | 1.32 | 0.71 | 0.75 | 0.86 | 1.12 | 1.12 | 1.60 | 2.42 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PE Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.91 | -27.60 |
PS Ratio | - | - | - | - | - | 861.78 | - | - | - | - | - | 32.34 | - | 18.30 | - | - | - | - | - | - | - |
PB Ratio | 1.62 | 1.77 | 1.55 | 1.62 | 7.03 | 7.95 | 5.95 | 8.89 | 8.70 | 6.98 | 10.79 | 6.40 | 2.19 | 2.24 | 1.72 | 1.70 | 1.96 | 1.55 | 1.43 | 1.46 | 2.21 |
P/TBV Ratio | 1.69 | 1.79 | 1.56 | 1.64 | 7.13 | 8.02 | 6.01 | 8.99 | 8.80 | 7.06 | 11.04 | 6.54 | 3.85 | 3.94 | 1.72 | 1.70 | 1.96 | 2.37 | 2.19 | 2.02 | 3.07 |
P/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -5.87 | - | - | - | - | - | - | - | - |
P/OCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -5.87 | - | - | - | - | - | - | - | - |
EV Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
EV/Sales Ratio | - | - | - | - | - | 738.31 | - | - | - | - | - | 28.17 | - | 12.46 | - | - | - | - | - | - | - |
EV/FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -4.35 | - | - | - | - | - | - | - | - |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | 0.04 | 0.04 | - | 0.01 | 0.01 | 0.01 | 0.01 | 0.11 | 0.09 | 0.08 | 0.14 | 0.12 | 0.16 | 0.16 | 0.30 | 0.30 | 0.30 | 0.26 | 0.26 | 0.19 | 0.19 |
Debt / EBITDA Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | 36.52 | - | - | - | - | - | - | - |
Debt / FCF Ratio | - | - | - | - | - | - | - | - | - | - | - | - | -0.43 | - | - | - | - | - | - | - | - |
Net Debt / Equity Ratio | -1.01 | -1.01 | -1.06 | -1.00 | -1.04 | -1.02 | -1.03 | -1.04 | -1.02 | -1.03 | -0.99 | -1.02 | -0.57 | -0.57 | -1.03 | -1.03 | -1.03 | -0.84 | -0.84 | -0.88 | -0.88 |
Net Debt / EBITDA Ratio | 0.90 | 0.90 | 1.03 | 1.09 | 1.08 | 1.26 | 1.32 | 1.40 | 1.97 | 2.18 | 1.70 | 1.94 | 1.27 | 1.09 | 1.03 | 0.97 | 0.96 | 1.29 | 1.83 | 3.76 | 3.88 |
Net Debt / FCF Ratio | 1.15 | 1.15 | 1.34 | 1.32 | 1.48 | 1.69 | 1.86 | 1.93 | 2.44 | 4.06 | 2.15 | 2.44 | 1.52 | 0.95 | 1.11 | 1.04 | 1.09 | 1.58 | 2.87 | 13.93 | 12.08 |
Asset Turnover | - | - | 0.01 | 0.01 | 0.01 | 0.01 | - | - | - | 0.01 | - | 0.14 | - | 0.08 | - | - | - | - | 0.14 | 0.39 | 0.39 |
Quick Ratio | 5.64 | 5.64 | 6.17 | 9.99 | 8.35 | 7.92 | 8.65 | 5.28 | 5.87 | 5.78 | 4.57 | 6.45 | - | 3.03 | - | 2.89 | 2.89 | 2.25 | 2.25 | 7.66 | 7.66 |
Current Ratio | 5.88 | 5.88 | 6.48 | 10.47 | 8.71 | 8.13 | 8.92 | 5.40 | 6.10 | 6.07 | 4.86 | 6.72 | - | 3.11 | - | 3.09 | 3.09 | 2.32 | 2.32 | 7.92 | 7.92 |
Return on Equity (ROE) | -67.85% | -67.85% | -75.87% | -82.21% | -69.79% | -74.61% | -91.70% | -77.58% | -62.11% | -48.47% | -55.90% | -57.81% | -49.35% | -39.18% | -61.74% | -53.63% | -42.06% | -24.65% | -3.86% | 34.85% | -19.44% |
Return on Assets (ROA) | -42.46% | -42.46% | -41.21% | -39.10% | -39.81% | -35.13% | -47.59% | -39.99% | - | -23.86% | - | -23.57% | - | -18.81% | - | -28.67% | -28.66% | -21.02% | -15.68% | -13.82% | -13.87% |
Return on Invested Capital (ROIC) | - | - | - | - | - | - | - | - | - | - | - | - | -105.04% | -170.18% | - | - | - | -242.92% | -135.18% | -12.74% | -40.74% |
Return on Capital Employed (ROCE) | -113.90% | -113.90% | -104.30% | -91.90% | -95.30% | -81.00% | -77.80% | -73.10% | -51.10% | -47.00% | -57.10% | -47.60% | - | -48.00% | - | -103.70% | -105.20% | -62.80% | -44.40% | -18.40% | -18.60% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 4, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | -49.30% | -55.41% | -67.80% | -63.15% | -12.68% | -11.50% | -13.19% | -7.98% | -7.18% | -6.71% | -5.70% | -9.11% | -18.60% | -20.55% | -49.58% | -50.53% | -34.06% | -17.88% | -2.59% | 10.09% | -3.62% |
FCF Yield | -52.96% | -49.98% | -51.17% | -46.74% | -9.99% | -7.64% | -9.28% | -6.06% | -4.78% | -3.65% | -4.30% | -6.54% | -17.04% | -26.73% | -54.09% | -58.04% | -48.10% | -34.41% | -20.44% | -4.33% | -3.29% |
Buyback Yield / Dilution | -2.30% | -0.52% | -2.23% | -3.27% | -3.87% | -12.32% | -12.00% | -10.75% | -12.43% | -13.26% | -12.23% | -12.42% | -10.04% | -7.63% | -6.86% | -9.66% | -9.66% | -7.55% | -7.55% | -1.35% | -1.35% |